| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.
Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.
The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $650.78 | $65,078.46 | -0.4% | -11.6% | +22.5% | |
| Apr 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $692.81 | $69,281.16 | -0.4% | -14.9% | +18.3% | |
| Mar 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $618.37 | $61,836.73 | -0.4% | +9.5% | +26.9% | |
| Feb 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $607.14 | $60,714.26 | -0.4% | +6.3% | +23.6% | |
| Jan 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $624.95 | $62,494.78 | -0.4% | +11.4% | +14.9% | |
| Dec 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $637.53 | $63,752.83 | -0.4% | -3.7% | +20.7% | |
| Nov 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $642.52 | $64,251.60 | -0.4% | -4.8% | +18.9% | |
| Oct 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $569.49 | $56,949.07 | -0.4% | +12.6% | +20.7% | |
| Sep 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $676.28 | $67,628.34 | -0.4% | -6.5% | -11.8% | |
| Aug 2, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $577.95 | $57,794.61 | -0.4% | +10.7% | -0.4% |